Van De Donk N, Wester R, Nijhof I, Albrecht C, Morano R, Entrala C, Van Nimwegen K. P50 | INPATIENT VS. OUTPATIENT TREATMENT MANAGEMENT WITH TECLISTAMAB IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A COST AND HEALTHCARE RESOURCE UTILIZATION ANALYSIS. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14040.